(19)
(11) EP 2 567 232 A1

(12)

(43) Date of publication:
13.03.2013 Bulletin 2013/11

(21) Application number: 11720657.3

(22) Date of filing: 04.05.2011
(51) International Patent Classification (IPC): 
G01N 33/50(2006.01)
(86) International application number:
PCT/US2011/035213
(87) International publication number:
WO 2011/140234 (10.11.2011 Gazette 2011/45)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 07.05.2010 US 332545 P

(71) Applicant: AbbVie Inc.
North Chicago, IL 60064 (US)

(72) Inventors:
  • MCKEEGAN, Evelyn M.
    Lake Forest Illinois 60045 (US)
  • ANSELL, Peter
    Grayslake Illinois 60030 (US)
  • DOWELL, Barry L.
    Mundelein Illinois 60060 (US)
  • ZHANG, Ke
    Grand Forks North Dakota 58203 (US)
  • DEVANARAYAN, Viswanath
    Souderton Pennsylvania 18964 (US)

(74) Representative: Modiano, Micaela Nadia et al
Modiano & Partners Thierschstrasse 11
80538 München
80538 München (DE)

   


(54) METHODS FOR PREDICTING SENSITIVITY TO TREATMENT WITH A TARGETED TYROSINE KINASE INHIBITOR